Great Valley Advisor Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,754
| Closed | -$309K | – | 833 |
|
|
2024
Q2 | $309K | Sell |
3,754
-533
| -12% | -$43.9K | 0.01% | 636 |
|
|
2024
Q1 | $374K | Sell |
4,287
-1,028
| -19% | -$89.8K | 0.01% | 556 |
|
|
2023
Q4 | $512K | Sell |
5,315
-445
| -8% | -$42.9K | 0.02% | 455 |
|
|
2023
Q3 | $510K | Hold |
5,760
| – | – | 0.02% | 430 |
|
|
2023
Q2 | $499K | Sell |
5,760
-235
| -4% | -$20.4K | 0.02% | 446 |
|
|
2023
Q1 | $583K | Sell |
5,995
-19
| -0.3% | -$1.85K | 0.03% | 407 |
|
|
2022
Q4 | $622K | Sell |
6,014
-92
| -2% | -$9.52K | 0.03% | 403 |
|
|
2022
Q3 | $518K | Sell |
6,106
-3,828
| -39% | -$325K | 0.03% | 412 |
|
|
2022
Q2 | $823K | Buy |
9,934
+5,944
| +149% | +$492K | 0.05% | 336 |
|
|
2022
Q1 | $314K | Buy |
3,990
+1,525
| +62% | +$120K | 0.02% | 479 |
|
|
2021
Q4 | $218K | Buy |
+2,465
| New | +$218K | 0.01% | 558 |
|